In the era of systems biology, multi-target pharmacological strategies hold promise for tackling disease-related networks. In this regard, drug promiscuity may be leveraged to interfere with multiple receptors: the so-called polypharmacology of drugs can be anticipated by analyzing the similarity of binding sites across the proteome. Here, we perform a pairwise comparison of 90,000 putative binding pockets detected in 3,700 proteins, and find that 23,000 pairs of proteins have at least one similar cavity that could, in principle, accommodate similar ligands. By inspecting these pairs, we demonstrate how the detection of similar binding sites expands the space of opportunities for the rational design of drug polypharmacology. Finally, we ill...
Abstract—From a network medicine perspective, diseases are caused by perturbations in the dynamics o...
We describe a computational protocol to aid the design of small molecule and peptide drugs that targ...
Conventional drug design embraces the "one gene, one drug, one disease" philosophy. Polypharmacology...
© Springer Science+Business Media LLC 2017. The administration of drugs is a key strategy in pharmac...
© 2018 The Author(s) 2018. Published by Oxford University Press. All rights reserved. Interactions b...
The quest for “magic bullets” has been the driving force in drug discovery during the last two decad...
Cancer is a leading cause of death worldwide. Development of new cancer drugs is increasingly costly...
The clinical efficacy and safety of a drug is determined by its activity profile across multiple pro...
In recent years, polypharmacology has gained popularity in drug discovery. [1] Especially for compl...
Background: Polypharmacology, defined as the modulation of multiple proteins rather than a single ta...
Background: Polypharmacology, defined as the modulation of multiple proteins rather than a single ta...
Several drugs exert their therapeutic effect through the modulation of multiple targets. Structure-b...
Abstract: The cellular network and its environment govern cell and organism behavior and are fundame...
Multi-target drugs have raised considerable interest in the last decade owing to their advantages in...
Polypharmacology is beginning to emerge as an important concept in the field of drug discovery. Howe...
Abstract—From a network medicine perspective, diseases are caused by perturbations in the dynamics o...
We describe a computational protocol to aid the design of small molecule and peptide drugs that targ...
Conventional drug design embraces the "one gene, one drug, one disease" philosophy. Polypharmacology...
© Springer Science+Business Media LLC 2017. The administration of drugs is a key strategy in pharmac...
© 2018 The Author(s) 2018. Published by Oxford University Press. All rights reserved. Interactions b...
The quest for “magic bullets” has been the driving force in drug discovery during the last two decad...
Cancer is a leading cause of death worldwide. Development of new cancer drugs is increasingly costly...
The clinical efficacy and safety of a drug is determined by its activity profile across multiple pro...
In recent years, polypharmacology has gained popularity in drug discovery. [1] Especially for compl...
Background: Polypharmacology, defined as the modulation of multiple proteins rather than a single ta...
Background: Polypharmacology, defined as the modulation of multiple proteins rather than a single ta...
Several drugs exert their therapeutic effect through the modulation of multiple targets. Structure-b...
Abstract: The cellular network and its environment govern cell and organism behavior and are fundame...
Multi-target drugs have raised considerable interest in the last decade owing to their advantages in...
Polypharmacology is beginning to emerge as an important concept in the field of drug discovery. Howe...
Abstract—From a network medicine perspective, diseases are caused by perturbations in the dynamics o...
We describe a computational protocol to aid the design of small molecule and peptide drugs that targ...
Conventional drug design embraces the "one gene, one drug, one disease" philosophy. Polypharmacology...